255 related articles for article (PubMed ID: 20821239)
21. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
Chao Y; Shih YL; Chiu JH; Chau GY; Lui WY; Yang WK; Lee SD; Huang TS
Cancer Res; 1998 Mar; 58(5):985-90. PubMed ID: 9500460
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor pathway inhibitor-2 silencing promotes hepatocellular carcinoma cell invasion in vitro.
Zhu B; Zhang P; Zeng P; Huang Z; Dong TF; Gui YK; Zhang GW
Anat Rec (Hoboken); 2013 Nov; 296(11):1708-16. PubMed ID: 24591127
[TBL] [Abstract][Full Text] [Related]
25. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
Yang SZ; Dong JH; Li K; Zhang Y; Zhu J
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
[TBL] [Abstract][Full Text] [Related]
26. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
28. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
29. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
30. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
32. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
33. The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line.
Wang GL; Chen L; Wei YZ; Zhou JM; Wu YY; Zhang YX; Qin J; Zhu YY
Oncol Rep; 2012 Jun; 27(6):1944-52. PubMed ID: 22378020
[TBL] [Abstract][Full Text] [Related]
34. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
36. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma.
Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY
Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
38. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Wang SM; Ooi LL; Hui KM
Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
[TBL] [Abstract][Full Text] [Related]
40. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
